Catalyst

Slingshot members are tracking this event:

InspireMD (NSPR) Announces 12-Month Follow-Up Data on CGuard Embolic Prevention System (EPS) at the Transcatheter Cardiovascular Therapeutics (TCT) 2016 Scientific Symposium

Source Link:
http://www.nasdaq.com/press-release/inspiremd-cguardtm-embolic-prevention-system-12month-clinical-trial-data-further-validate-potentia-20161101-00291

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
NSPR
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Nov 01, 2016
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords 12-month Follow-up Data, Cguard, Embolic Prevention System, Eps
About Us
Media Center
Connect with Us
© 2026 Slingshot Insights. All rights reserved.